Literature DB >> 7379336

Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants.

E J Glass, A B Kay.   

Abstract

The capacity of various leucoattractants to enhance, or unfold, receptors for complement (C3b) on human blood monocytes has been studied. A number of recognized monocyte chemoattractants including casein, supernatants from C. parvum 10390 and from human lymphocytes (cultured either in the presence or absence of phytohaemagglutinin) and the formyl-methionyl peptides, F-Met-Leu-Phe, F-Met-Met-Phe and F-Met-Phe, increased the percentage of monocytes which formed rosettes with IgM-sensitized sheep erythrocytes coated with complement. Comparable results were achieved irrespective of whether purified components of whole serum was used as a source of complement. In contrast, there was no significant increase in EAG (Fc) rosettes with those doses of casein which gave enhancement of C3b receptors. A small degree of complement receptor enhancement was observed with histamine but the unformylated peptides, Met-Leu-Phe and Met-Met-Phe, were without apparent effect. Maximal receptor enhancement was obtained at 30 min but when the leucoattractant was removed, enhancement was reversible, returning to normal values in approximately 120 min. Monocyte complement receptor enhancement increased with temperatures between 0 degrees C and 37 degrees C. These data (1) confirm and extend our previous findings on leucoattractant-induced enhancement of complement receptors on human monocytes; (2) indicate that the phenomenon may have potential as a clinical test for monocyte function both in health and disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7379336      PMCID: PMC1538109     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  A lipid chemotactic factor from anaerobic coryneform bacteria including Corynebacterium parvum with activity for macrophages and monocytes.

Authors:  R J Russell; R J McInroy; P C Wilkinson; R G White
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

2.  The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors.

Authors:  A R Anwar; A B Kay
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

3.  Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia.

Authors:  A R Anwar; A B Kay
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

4.  Role of anaerobic coryneforms in specific and non-specific immunological reactions. II. Production of a chemotactic factor specific for macrophages.

Authors:  P C Wilkinson; G J O'Neill; K G Wapshaw
Journal:  Immunology       Date:  1973-06       Impact factor: 7.397

5.  Studies on chemotaxis. VI. Specific chemotaxis in rabbit polymorphonuclear leucocytes and mononuclear cells.

Authors:  H U Keller; E Sorkin
Journal:  Int Arch Allergy Appl Immunol       Date:  1967

6.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.

Authors:  R Snyderman; L C Altman; M S Hausman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

7.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

8.  Enhancement of human eosinophil complement receptors by pharmacologic mediators.

Authors:  A R Anwar; B Kay
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

9.  Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines.

Authors:  E M Shevach; R Herberman; M M Frank; I Green
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

10.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  12 in total

1.  Chemotactic factor-induced enhancement of the binding of human immunoglobulin classes and subclasses to neutrophils and eosinophils.

Authors:  A B Kay; G M Walsh
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

2.  Defective chemotactic factor-induced monocyte complement receptor enhancement in lung cancer.

Authors:  M Carroll; K Lukacs; M Hodson; A B Kay
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

Review 3.  Macrophage activation, chronic inflammation and gastrointestinal disease.

Authors:  A R Tanner; M J Arthur; R Wright
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

Review 4.  Synthesis of complement by macrophages and modulation of their functions through complement activation.

Authors:  H P Hartung; U Hadding
Journal:  Springer Semin Immunopathol       Date:  1983

5.  Demonstration of specific receptors for fluoresceinated casein on human neutrophils and monocytes using flow cytometry.

Authors:  S L Lewis; D E Van Epps
Journal:  Inflammation       Date:  1983-12       Impact factor: 4.092

6.  Receptor associated defects of cultured monocytes in bronchial carcinoma.

Authors:  K Lukacs; M P Carroll; M E Hodson; A B Kay
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

7.  Corticosteroid-resistant chronic asthma and monocyte complement receptors.

Authors:  A B Kay; P Diaz; J Carmicheal; I W Grant
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

8.  Lymphoblastoid cell supernatants increase expression of C3b receptors on human polymorphonuclear leucocytes: direct binding studies with 125I-C3b.

Authors:  M Berger; A S Cross
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

9.  Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products.

Authors:  L Nagy; T H Lee; E J Goetzl; W C Pickett; A B Kay
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

10.  Inhibition of monocyte complement receptor enhancement by low molecular weight material from human lung cancers.

Authors:  E J Glass; C A Abell; A B Kay
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.